Literature DB >> 30032138

Human Cervical Epithelial Cells Release Antiviral Factors and Inhibit HIV Replication in Macrophages.

Xi-Qiu Xu1, Le Guo1, Xu Wang2, Yu Liu1, Hang Liu1, Run-Hong Zhou1, Jun Gu1, Jin-Biao Liu3, Pei Xu4, Li Zhou5, Wen-Zhe Ho1,2.   

Abstract

The female reproductive tract is a major site of HIV sexual transmission. We here examined whether human cervical epithelial cells (HCEs) can be immunologically activated and produce antiviral factors against HIV. We demonstrated that HCEs (End1/E6E7 cells) possess the functional toll-like receptor (TLR)3 signaling system, which could be activated by Poly I:C and induce multiple cellular HIV restriction factors. The treatment of primary human macrophages with supernatant (SN) from TLR3-activated End1/E6E7 cell cultures resulted in HIV inhibition. This SN-mediated HIV inhibition was mainly through the induction of interferons (IFN)-β and IFN-λs, as the antibodies to IFN-β or IFN-λs receptor could effectively block the SN-mediated anti-HIV effect. Further studies showed that the incubation of macrophages with SN from the activated cervical epithelial cell cultures induced the expression of a number of IFN-stimulated genes (ISGs), including IFN-stimulated gene (ISG15), ISG56, 2', 5'-oligoadenylate synthetase 1 (OAS 1), OAS 2, Myxovirus Resistance A (MxA), MxB, and Guanylate-binding protein 5 (GBP5). In addition, TLR3-activated cells produced the CC chemokines [regulated on activation, normal T cell expressed and secreted (RANTES), Human macrophage inflammatory protein 1 alpha (MIP-1α), MIP-1β] the ligands of HIV entry co-receptor CCR5. These observations support further studies on HCEs as potentially crucial and alternative targets for immunological intervention to control and prevent HIV sexual transmission.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  HIV; Human cervical epithelial cells; Interferon-stimulated genes; Macrophages; Toll-like receptor 3

Mesh:

Substances:

Year:  2018        PMID: 30032138      PMCID: PMC6338329          DOI: 10.1159/000490586

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  38 in total

1.  Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia.

Authors:  Caitlin D Blaskewicz; Jeffrey Pudney; Deborah J Anderson
Journal:  Biol Reprod       Date:  2011-04-06       Impact factor: 4.285

2.  Induction of interferon-γ contributes to Toll-like receptor 3-mediated herpes simplex virus type 1 inhibition in astrocytes.

Authors:  Jieliang Li; Li Ye; Xu Wang; Shuxian Hu; Wenzhe Ho
Journal:  J Neurosci Res       Date:  2011-11-04       Impact factor: 4.164

3.  Small-molecule inhibitors of the TLR3/dsRNA complex.

Authors:  Kui Cheng; Xiaohui Wang; Hang Yin
Journal:  J Am Chem Soc       Date:  2011-02-28       Impact factor: 15.419

4.  Suppression of type I and type III IFN signalling by NSs protein of severe fever with thrombocytopenia syndrome virus through inhibition of STAT1 phosphorylation and activation.

Authors:  Vidyanath Chaudhary; Shuo Zhang; Kit-San Yuen; Chuan Li; Pak-Yin Lui; Sin-Yee Fung; Pei-Hui Wang; Chi-Ping Chan; Dexin Li; Kin-Hang Kok; Mifang Liang; Dong-Yan Jin
Journal:  J Gen Virol       Date:  2015-11       Impact factor: 3.891

5.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.

Authors:  Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Zhijian J Chen
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

6.  Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2.

Authors:  Cheryl J Hertz; Qi Wu; Edith Martin Porter; Yan J Zhang; Karl-Heinz Weismüller; Paul J Godowski; Tomas Ganz; Scott H Randell; Robert L Modlin
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

7.  Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo.

Authors:  Mohan R Dasu; Andrea C Riosvelasco; Ishwarlal Jialal
Journal:  Atherosclerosis       Date:  2008-04-18       Impact factor: 5.162

8.  Interferon lambda 1 expression in cervical cells differs between low-risk and high-risk human papillomavirus-positive women.

Authors:  Fabiana Cannella; Carolina Scagnolari; Carla Selvaggi; Patrizia Stentella; Nadia Recine; Guido Antonelli; Alessandra Pierangeli
Journal:  Med Microbiol Immunol       Date:  2014-02-08       Impact factor: 3.402

9.  HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa.

Authors:  Anne Hoppe; Marina Giuliano; Abbas Lugemwa; Jennifer A Thompson; Marco Floridia; Ann S Walker; Ismail Senoga; Mary C Abwola; Maria F Pirillo; Cissy M Kityo; Alejandro Arenas-Pinto; Nicholas I Paton
Journal:  Antivir Ther       Date:  2018

10.  IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.

Authors:  Fatma Aboulnasr; Sidhartha Hazari; Satyam Nayak; Partha K Chandra; Rajesh Panigrahi; Pauline Ferraris; Srinivas Chava; Ramazan Kurt; Kyongsub Song; Asha Dash; Luis A Balart; Robert F Garry; Tong Wu; Srikanta Dash
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

View more
  7 in total

Review 1.  Functions of IFNλs in Anti-Bacterial Immunity at Mucosal Barriers.

Authors:  Noémie Alphonse; Ruth E Dickenson; Abrar Alrehaili; Charlotte Odendall
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

2.  Exosomes Transport Anti-Human Immunodeficiency Virus Factors from Human Cervical Epithelial Cells to Macrophages.

Authors:  Xi-Qiu Xu; Biao Zhang; Le Guo; Yu Liu; Feng-Zhen Meng; Xu Wang; Wen-Hui Hu; Adil I Khan; Wen-Zhe Ho
Journal:  J Innate Immun       Date:  2021-06-03       Impact factor: 7.349

3.  Methadone Inhibits Viral Restriction Factors and Facilitates HIV Infection in Macrophages.

Authors:  Mei-Rong Wang; Di-Di Wu; Fan Luo; Chao-Jie Zhong; Xin Wang; Ni Zhu; Ying-Jun Wu; Hai-Tao Hu; Yong Feng; Xu Wang; Hai-Rong Xiong; Wei Hou
Journal:  Front Immunol       Date:  2020-07-03       Impact factor: 7.561

4.  Bowman‒Birk Inhibitor Suppresses Herpes Simplex Virus Type 2 Infection of Human Cervical Epithelial Cells.

Authors:  Yu Liu; Xi-Qiu Xu; Biao Zhang; Jun Gu; Feng-Zhen Meng; Hang Liu; Li Zhou; Xu Wang; Wei Hou; Wen-Zhe Ho
Journal:  Viruses       Date:  2018-10-12       Impact factor: 5.048

5.  Poly(dA:dT) Suppresses HSV-2 Infection of Human Cervical Epithelial Cells Through RIG-I Activation.

Authors:  Dan-Dan Shao; Feng-Zhen Meng; Yu Liu; Xi-Qiu Xu; Xu Wang; Wen-Hui Hu; Wei Hou; Wen-Zhe Ho
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

6.  Complement-Opsonized HIV Modulates Pathways Involved in Infection of Cervical Mucosal Tissues: A Transcriptomic and Proteomic Study.

Authors:  Cecilia Svanberg; Rada Ellegård; Elisa Crisci; Mohammad Khalid; Ninnie Borendal Wodlin; Maria Svenvik; Sofia Nyström; Kenzie Birse; Adam Burgener; Esaki M Shankar; Marie Larsson
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

7.  The Removal of HBV in Plasma by Extracorporeal Immunoadsorption from Plasma: A Potential Therapy of Hepatitis B Patients.

Authors:  Zhenwei Han; Xuan Lu; Yiping Tang; Yuanyuan Yang; Qiuchen Liu; Pengfei Cheng; Li Zhou; Yefu Wang
Journal:  Biomed Res Int       Date:  2018-12-23       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.